Résumé
Objective: adhesive capsulitis is a common condition in which the shoulder capsule swells and stiffens, restricting its mobility. It is a common cause of shoulder pain and disability, estimated to affect 25% of the general population. The objective of the study was to compare the mean decrease of pain scores [according to ULCA shoulder rating scale] with intra-articular nonsteroidal anti-inflammatory [NSAID] injection versus steroid injection for the management of adhesive capsulitis of the shoulder
Material and Methods: a randomized controlled trial was carried out in Department of Orthopedic Surgery at Services Hospital Lahore from September 2012 to March 2013. A total of 150 patients with adhesive capsulitis of the shoulder were included in the study and were assigned into two groups using random number table. Group A patients received intra-articular NSAID [Ketorolac] and Group B patients were treated with intra-articular steroid [Triamcinolone] injection for the treatment of adhesive capsulitis. The pain scores were recorded before and four weeks after the intra-articular injections using ULCA shoulder rating scale
Results: the age distribution of the 150 patients shows that majority of the patients i.e. 37.33% [n=28] in Group A and 33.33% [n=25] in Group B were between 51 -60 years, mean and SD was calculated as 53.55+/-5.11 and 55.21+/-5.76 years respectively. In Group-A45.33% [n=34] and in Group-B 48% [n=36] were males whereas 54.67% [n=41] and 52% [n=39] were females. The pre-treatment pain score in both groups was recorded as 4.43+/-1.76 in Group A and 5.92+/-1.31 in Group B. The post-treatment pain score was 7.95+/-0.32 in Group A and 6.7620.63 in Group B [p=0.01], showing significant difference in both groups
Conclusion: the intra-articular NSAIDs injection is a more effective treatment option compared to intra-articular steroid injection for the management of adhesive capsulitis of the shoulder